Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2014/417091 http://scihub22266oqcxt.onion/10.1155/2014/417091 C4055613!4055613 !24982880     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24982880 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Biomed+Res+Int 2014 ; 2014 (ä): 417091 Nephropedia Template TP {{tp|p=24982880 |t=2014. Radiopharmaceutical stem cell tracking for neurological diseases |pdf=|usr=}}{{24982880 }} gab.com Text Radiopharmaceutical stem cell tracking for neurological diseases JO: Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=24982880 #FOAvip Although neurological ailments continue to be some of the main causes of disease burden in the world, current therapies such as pharmacological agents have limited potential in the restoration of neural functions. Cell therapies, firstly applied to treat different hematological diseases, are now being investigated in preclinical and clinical studies for neurological illnesses. However, the potential applications and mechanisms for such treatments are still poorly comprehended and are the focus of permanent research. In this setting, noninvasive in vivo imaging allows better understanding of several aspects of stem cell therapies. Amongst the various methods available, radioisotope cell labeling has become one of the most promising since it permits tracking of cells after injection by different routes to investigate their biodistribution. A significant increase in the number of studies utilizing this method has occurred in the last years. Here, we review the different radiopharmaceuticals, imaging techniques, and findings of the preclinical and clinical reports published up to now. Moreover, we discuss the limitations and future applications of radioisotope cell labeling in the field of cell transplantation for neurological diseases. Twit Text FOAVip Radiopharmaceutical stem cell tracking for neurological diseases ????Biomed Res Int http://www.kidney.de/pget.php?&tw=1&pmid=24982880 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24982880 #FOAvip English Wikipedia <ref>{{Cite pmid|24982880 }}</ref> Radiopharmaceutical stem cell tracking for neurological diseases #MMPMID24982880 Rosado-de-Castro PH ; Pimentel-Coelho PM ; Gutfilen B ; Lopes de Souza SA ; de Freitas GR ; Mendez-Otero R ; Barbosa da Fonseca LM Biomed Res Int 2014[]; 2014 (ä): 417091 PMID24982880 show ga Although neurological ailments continue to be some of the main causes of disease burden in the world, current therapies such as pharmacological agents have limited potential in the restoration of neural functions. Cell therapies, firstly applied to treat different hematological diseases, are now being investigated in preclinical and clinical studies for neurological illnesses. However, the potential applications and mechanisms for such treatments are still poorly comprehended and are the focus of permanent research. In this setting, noninvasive in vivo imaging allows better understanding of several aspects of stem cell therapies. Amongst the various methods available, radioisotope cell labeling has become one of the most promising since it permits tracking of cells after injection by different routes to investigate their biodistribution. A significant increase in the number of studies utilizing this method has occurred in the last years. Here, we review the different radiopharmaceuticals, imaging techniques, and findings of the preclinical and clinical reports published up to now. Moreover, we discuss the limitations and future applications of radioisotope cell labeling in the field of cell transplantation for neurological diseases. |*Radiopharmaceuticals [MESH] |Animals [MESH] |Cell Tracking/*methods [MESH] |Clinical Trials as Topic [MESH] |Humans [MESH] |Nervous System Diseases/*diagnostic imaging/*pathology [MESH] |Radionuclide Imaging [MESH] |Staining and Labeling [MESH]Radiopharmaceutical stem cell tracking for neurological diseases (epmc).pdf DeepDyve Pubget Overpricing